ZVSA — Zyversa Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Zyversa Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS/A	PROSPECTUS/A	PROSPECTUS/A	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.175	0.329	5.9	3.14
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.339	0.812	6.36	3.35
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.038	0.028	0.116	0.015
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	0.686	1.13	119	22.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7.56	13.6	8.19	10.2
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	9.24	13.6	18.5	11
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	-8.56	-12.5	100	11.1
Total Liabilities & Shareholders' Equity	0.686	1.13	119	22.1
Total Common Shares Outstanding
Total Preferred Shares Outstanding